World's Best Scientists 2026 revealed!
Award Badge
Medicine
Taiwan
2023

D-Index & Metrics

Medicine

D-Index
95
Citations
37384
World Ranking
9977
National Ranking
18

Shou-Dong Lee publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Shou-Dong Lee sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 913 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Shou-Dong Lee D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Shou-Dong Lee sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Taiwan Leader Award
  • 2022 - Research.com Medicine in Taiwan Leader Award

Overview

Shou-Dong Lee is affiliated with Taipei Veterans General Hospital in Taiwan, focusing primarily on the field of Medicine with a particular emphasis on Epidemiology, Hepatology, Molecular Biology, Oncology, and Surgery. Their research contributions span several subfields, reflecting a multidisciplinary approach to liver diseases and viral hepatitis.

The main topics of Lee's work include hepatitis C virus research, liver disease diagnosis and treatment, hepatitis B virus studies, fibroblast growth factor research, epigenetics and DNA methylation, Kruppel-like factors research, as well as liver disease and transplantation. This range underlines an extensive engagement with both viral and molecular aspects of liver conditions.

Frequent co-authors collaborating with Lee include Yi-Hsiang Huang, Chi-Jen Chu, Chien-Wei Su, Jiing-Chyuan Luo, and Han-Mo Chiu. These partnerships indicate an active engagement within a research network contributing to the study of liver diseases and associated virology.

Lee's work has been published in various scientific venues. Notably, they have multiple publications in:

  • Advances in Digestive Medicine
  • Journal of the Chinese Medical Association
  • Nutrients
  • BioMed Research International

Selected recent papers authored by or associated with Lee cover topics related to viral hepatitis and liver disease treatment outcomes:

  • Fibroblast Growth Factor 19 and Fibroblast Growth Factor 21 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Gastric Bypass, 2022, Nutrients
  • Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety, and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis, 2021, Journal of the Chinese Medical Association
  • Well tolerability and highly effective treatment response for hepatitis C virus-human immunodeficiency virus-coinfected patients treated by all-oral direct-acting antivirals, 2021, Journal of the Chinese Medical Association
  • Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response, 2023, Journal of the Chinese Medical Association
  • Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients, 2024, Journal of the Chinese Medical Association

Best Publications

  • Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes

    Helene Norder;Anne-Marie Couroucé;Pierre Coursaget;José M Echevarria

  • Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.

    Howard A. Liebman;Barbara C. Furie;Myron J. Tong;Rita A. Blanchard

  • Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.

    William G.E. Cooksley;T. Piratvisuth;S.-D. Lee;V. Mahachai

  • Polymorphism of the N‐acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug–induced hepatitis

    Yi-Shin Huang;Herng-Der Chern;Wei-Juin Su;Jaw-Ching Wu

  • Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis.

    Yi Shin Huang;Herng Der Chern;Wei Juin Su;Jaw Ching Wu

  • Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.

    Robert G. Gish;Anna S. Lok;Ting Tsung Chang;Robert A. de Man

  • Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: A randomized trial

    Ming-Chih Hou;Han-Chieh Lin;Tsu-Te Liu;Benjamin Ing-Tieu Kuo

  • Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.

    Jaw-Ching Wu;Jaw-Ching Wu;Yi-Hsiang Huang;Yi-Hsiang Huang;Gar-Yang Chau;Gar-Yang Chau;Chien-Wei Su;Chien-Wei Su

  • Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen

    Heléne Norder;Berit Hammas;Shou-Dong Lee;Khalif Bile

  • Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation.

    Ren-Shin Lin;Fa-Yauh Lee;Shou-Dong Lee;Yang-Te Tsai

  • Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)

    J W M Chan;C K Ng;Y H Chan;T Y W Mok

  • A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N‐Butyl‐2‐Cyanoacrylate injection versus band ligation

    Pen-Chung Tan;Ming-Chih Hou;Han-Chieh Lin;Tsu-Te Liu

  • Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B

    Yi Hsiang Huang;Liang Tsai Hsiao;Ying Chung Hong;Tzeon Jye Chiou

  • Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial.

    Ming-Chih Hou;Han-Chieh Lin;Benjamin Ing-Tiau Kuo;Chen-Hsiang Chen

  • Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.

    Teh Ia Huo;Jaw Ching Wu;Pui Ching Lee;Gar Yang Chau

  • Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment

    Chi-Jen Chu;Shou-Dong Lee

  • Ghrelin Gene Products and the Regulation of Food Intake and Gut Motility

    Chih Yen Chen;Akihiro Asakawa;Mineko Fujimiya;Shou Dong Lee

  • HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis

    Keng-Hsin Lan;Meei-Ling Sheu;Shinn-Jang Hwang;Sang-Hue Yen

  • Familial Risk of Hepatocellular Carcinoma Among Chronic Hepatitis B Carriers and Their Relatives

    Ming-Whei Yu;Hung-Chuen Chang;Yun-Fan Liaw;Shi-Ming Lin

  • Genotypes and Viremia of Hepatitis B and D Viruses Are Associated With Outcomes of Chronic Hepatitis D Patients

    Chien–Wei Su;Chien–Wei Su;Yi–Hsiang Huang;Yi–Hsiang Huang;Teh–Ia Huo;Teh–Ia Huo;Hsuan Hui Shih

Frequent Co-Authors

Pei-Jer Chen
Pei-Jer Chen National Taiwan University
Chun-Jen Liu
Chun-Jen Liu National Taiwan University
Jen Chuen Hsieh
Jen Chuen Hsieh National Yang Ming Chiao Tung University
Myron J. Tong
Myron J. Tong University of California, Los Angeles
Chien-Jen Chen
Chien-Jen Chen Academia Sinica
Chang-Phone Fung
Chang-Phone Fung Taipei Veterans General Hospital
Yun-Fan Liaw
Yun-Fan Liaw Chang Gung Memorial Hospital
Shie-Liang Hsieh
Shie-Liang Hsieh Academia Sinica
Tzu Chen Yeh
Tzu Chen Yeh Taipei Veterans General Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying medicine in the USA, there are several alternative healthcare career pathways to explore—many of which can be pursued online for added convenience and flexibility. For those interested in advanced roles in teaching or leadership within nursing, doctorate in nursing education online programs offer a pathway to higher qualifications without interrupting your career.

Nurses aiming to advance their credentials can investigate the rn to bsn online cost to find affordable programs that enhance professional opportunities and earning potential. For individuals with a non-nursing background, the cheapest direct entry msn programs provide a fast-track route to becoming a registered nurse and entering the healthcare field.

Additionally, for those looking for accessible entry points into nursing, many students research adn programs as a practical way to start their healthcare careers. Each of these online degree options can open doors to rewarding roles in medicine and healthcare, allowing for greater flexibility and potential cost savings.

Best Scientists Citing Shou-Dong Lee

Trending Scientists

Recently Published Articles